Brief: Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
02/02/2024 12:35
Feb 2 (Reuters) - Eton Pharmaceuticals Inc ETON.O :
* ETON PHARMACEUTICALS ANNOUNCES COMMERCIAL AVAILABILITY OF
ULTRA-RARE DISEASE PRODUCT NITISINONE CAPSULES
* ETON PHARMACEUTICALS INC: PRODUCT IS NOW AVAILABLE
EXCLUSIVELY
THROUGH OPTIME CARE
Source text for Eikon: ID:nGNXbm3zWv
Further company coverage: ETON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eton Pharmaceuticals
See all newsBrief: Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - SEC Filing
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer